2. Academic Validation
  3. Novel Indoline Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness and CNS Disorders

Novel Indoline Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness and CNS Disorders

  • ACS Med Chem Lett. 2025 Jan 23;16(2):196-197. doi: 10.1021/acsmedchemlett.5c00004.
Ram W Sabnis 1,  Anika R Sabnis 2
Affiliations

Affiliations

  • 1 Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
  • 2 Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York 10029, United States.
PMID: 39967622 DOI: 10.1021/acsmedchemlett.5c00004
Abstract

Provided herein are novel indoline derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders and processes for preparing such compounds.

Figures
Products